Tag: Osteoporosis
Most Osteoporosis Guidelines Do Not Discuss Patient Choices
When patient beliefs, values, preferences are cited, they are not usually supported by evidence
ENDO: Recommendations Issued for Treating Osteoporosis
Pharmacological management recommended for postmenopausal women at high risk for fracture
AAOS: Supplement Use Low in Patients With Osteoporosis, Hip Fracture
Non-Caucasian minorities less likely to receive proper supplementation
Elderly Men Undertreated for Osteoporosis
Also, black men and women are much less likely to be treated than their white counterparts
Fewer Older Men Assessed, Treated for Osteoporosis
Fewer older men than women, even with higher risk, undergo DXA screening, 25(OH)D measurement
Rates of Osteonecrosis of the Jaw Low for Denosumab-Treated Women
Invasive oral procedures associated with increased incidence of ONJ, but rate low overall
Young Breast Cancer Patients Face Higher Risk for Osteoporosis
Women diagnosed before age 50 have twice the risk versus cancer-free peers
Denosumab Promising for TDT-Induced Osteoporosis Treatment
Higher percentage increase of L1 to L4 and wrist bone mineral density with DMN, reduction in pain
Drop in Osteoporosis Treatment Initiation After Hip Fracture
Adherence to regimen needed to cut subsequent fracture risk
USPSTF Favors Osteoporosis Screening to Prevent Fracture
Screening with bone measurement recommended for women aged ≥65, younger women at risk
